[
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=52847d5f6cef13f2af09c8c71b06b0acd088ca5189a45dcd5f7b5ce370ac359e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759410004,
      "headline": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 136960240,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=52847d5f6cef13f2af09c8c71b06b0acd088ca5189a45dcd5f7b5ce370ac359e"
    }
  },
  {
    "ts": null,
    "headline": "Gilead’s Lost Decade Is Over. It’s Time to Buy the Stock.",
    "summary": "Gilead looks attractive again. Its innovative edge and new crop of medications are performing well across multiple specialties.",
    "url": "https://finnhub.io/api/news?id=3d3d0f997234a92964907fcd809d131c047d578de6f34662f39afdb48f0c902e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759406400,
      "headline": "Gilead’s Lost Decade Is Over. It’s Time to Buy the Stock.",
      "id": 136955459,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead looks attractive again. Its innovative edge and new crop of medications are performing well across multiple specialties.",
      "url": "https://finnhub.io/api/news?id=3d3d0f997234a92964907fcd809d131c047d578de6f34662f39afdb48f0c902e"
    }
  }
]